Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted copies of newspaper advertisements published on 13th August 2025 in Business Line, Financial Express, and Nava Telangana, as required under SEBI listing rules. The publications cover two key items: (1) the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended 30th June 2025), approved by the Board on 12th August 2025, and (2) a notice declaring an interim dividend of Rs. 1.25 per equity share (on face value of Rs. 2 each). The record date for the dividend is set as 19th August 2025, with payment to shareholders on or after 28th August 2025.
Positive for shareholders — the interim dividend of Rs. 1.25/share rewards investors ahead of the annual results, while confirmation of Q1 results in newspaper format is a routine compliance step with no direct price impact. The actual Q1 earnings and dividend payout are the material events here.